Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy

Christina Tsien, Kent A. Griffith, Howard M. Sandler, Patrick McLaughlin, Martin G. Sanda, James Montie, Shilpa Reddy, James A. Hayman

    Research output: Contribution to journalArticlepeer-review

    50 Scopus citations


    Objectives. To evaluate the efficacy and toxicity of three-dimensional conformal radiotherapy (3D-CRT) in the adjuvant and salvage setting after radical prostatectomy (RP). Methods. From 1986 to 1997, 38 patients received adjuvant 3D-CRT, with a median time from RP to 3D-CRT of 2.8 months, and 57 patients were treated with salvage RT for a rising prostate-specific antigen with a median time to 3D-CRT of 27.7 months. The median radiation dose was 64.8 Gy. The median follow-up from completion of RT was 7.0 years (range 1.0 to 14.2). Results. Overall, the 8-year actuarial rate of biochemical disease-free survival was 40% in all patients. The 8-year biochemical disease-free survival rate was 45% (standard error [SE] 8%) and 30% (SE 7%) for the adjuvant and salvage group, respectively, from RT completion. When measured from the date of RP, the 5 and 8-year biochemical disease-free survival rate for salvage radiotherapy was 58% and 37%, respectively. The corresponding results for adjuvant RT were similar at 53% and 45%. On multivariate analysis, the Gleason score was the only prognostic factor predictive of prostate-specific antigen failure in the salvage group. No prognostic factor was significant in the adjuvant group. The prevalence of major complications after 3D-CRT was low using physician-reported data. Conclusions. Long-term biochemical control can be achieved in both adjuvant and salvage settings. For patients receiving salvage RT, a Gleason score greater than 7 was predictive of prostate-specific antigen failure. Prospective trials are needed to improve further on these results.

    Original languageEnglish
    Pages (from-to)93-98
    Number of pages6
    Issue number1
    StatePublished - Jul 1 2003


    Dive into the research topics of 'Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy'. Together they form a unique fingerprint.

    Cite this